| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
24,682 |
24,094 |
$2.05M |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
13,085 |
12,900 |
$1.11M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
7,074 |
7,070 |
$907K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,563 |
4,515 |
$264K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
5,086 |
5,039 |
$176K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
9,300 |
9,206 |
$126K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,000 |
3,964 |
$103K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
742 |
742 |
$63K |
| 87807 |
|
2,587 |
2,538 |
$31K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
69 |
69 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
12 |
12 |
$281.83 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
12 |
12 |
$234.96 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
13 |
13 |
$206.36 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
13 |
13 |
$1.60 |